Region: Global
Category: Life Sciences

Global Life Sciences

(45,012 reports matching your criteria)
  • Cholesterol Testing

    ... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the ... Read More

  • Laboratory Glassware and Plasticware

    ... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Glass Pipettes and Pipette Tips, one of the segments analyzed in the report, is expected to record a 1.5% CAGR and reach US$636.1 ... Read More

  • Gastrointestinal (GI) Endoscopy Devices

    ... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$25.5 ... Read More

  • ENT and Bronchoscopy Devices

    ... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$7.8 Billion by the end ... Read More

  • Hormone Replacement Therapy (HRT)

    ... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$24.2 Billion ... Read More

  • Anti-Counterfeit Packaging

    ... CAGR of 9.2% over the analysis period 2024-2030. Mass Encoding Technology, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$109.6 Billion by the end of the ... Read More

  • Heart Healthy Ingredients

    ... at a CAGR of 4.2% over the analysis period 2024-2030. Omega-3 Ingredient, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$12.4 Billion by the end of ... Read More

  • Acute Heart Failure (AHF) Therapeutics

    ... Billion by 2030, growing at a CAGR of 21.0% over the analysis period 2024-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.5% CAGR and reach US$762.4 Million ... Read More

  • Dental Implants

    ... CAGR of 6.1% over the analysis period 2024-2030. Titanium Material, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.2 Billion by the end of the analysis ... Read More

  • mHealth (Mobile Health) Services

    ... 2030, growing at a CAGR of 27.9% over the analysis period 2024-2030. Monitoring Services, one of the segments analyzed in the report, is expected to record a 27.0% CAGR and reach US$139.8 Billion by the ... Read More

  • Biomarkers

    ... 13.7% over the analysis period 2024-2030. Safety Biomarkers, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$89.8 Billion by the end of the analysis period. Growth ... Read More

  • Prenatal Diagnostics

    ... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis ... Read More

  • Circulating Tumor Cell (CTC) Diagnostics

    ... Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Detection & Enrichment Technology, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More

  • Biosimulation Technology

    ... CAGR of 15.6% over the analysis period 2024-2030. Biosimulation Software, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$5.7 Billion by the end of the analysis ... Read More

  • Biopreservation

    ... 8.0% over the analysis period 2024-2030. Biopreservation Media, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth ... Read More

  • Dental Preventive Supplies

    ... at a CAGR of 4.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$156.3 Million While China is Forecast to Grow at 6.4% CAGR The Dental Preventive Supplies market in the U.S. ... Read More

  • Acute Coronary Syndrome

    ... at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 16.2% CAGR The Acute Coronary Syndrome market in the U.S. ... Read More

  • Sports Nutrition Supplements

    ... at a CAGR of 5.8% over the analysis period 2024-2030. Amino Acids / Derivatives, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.6 Billion by the ... Read More

  • Arthroscopy Instruments

    ... CAGR of 7.0% over the analysis period 2024-2030. Arthroscopy Implants, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.8 Billion by the end of the analysis ... Read More

  • Medical X-Ray

    ... CAGR of 5.1% over the analysis period 2024-2030. Digital Technology, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$13.5 Billion by the end of the analysis ... Read More

  • Cables and Leads for Medical Equipment

    ... reach US$6.0 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. ECG Application, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach ... Read More

  • Cardiac Defibrillators

    ... CAGR of 7.9% over the analysis period 2024-2030. Implantable / Internal Cardiac Defibrillator, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.3 Billion by the end ... Read More

  • Imaging Agents

    ... CAGR of 4.5% over the analysis period 2024-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More

  • Mammography Equipment

    ... CAGR of 6.8% over the analysis period 2024-2030. 2-D Digital Mammography Systems, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.1 Billion by the end of ... Read More

  • Pulse Oximeters

    ... CAGR of 3.7% over the analysis period 2024-2030. Handheld Pulse Oximeters, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$1.5 Billion by the end of the ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings